CIK 0002022626 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Upstream Bio, Inc.
Sign in to watch- Ticker
- UPB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 781-208-2466
- Business address
- 890 WINTER STREET, SUITE 200, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $27,604
- in 5 filings
Net −$27,604. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-16 | Houghton Adam Chief Business Officer | Sale | −699 | $9.29 | $6K | 24,301 |
| 2026-01-02 | GRAY MICHAEL CFO and COO | Grant or award | +30,500 | 30,500 | ||
| 2026-01-02 | GRAY MICHAEL CFO and COO | Grant or award · Stock Option (Right to Buy) | +91,500 | 91,500 | ||
| 2026-01-02 | Deykin Aaron Chief Medical Officer | Grant or award | +32,000 | 33,581 | ||
| 2026-01-02 | Deykin Aaron Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +96,000 | 96,000 | ||
| 2026-01-02 | Ambrose Allison General Counsel | Grant or award | +17,000 | 17,000 | ||
| 2026-01-02 | Ambrose Allison General Counsel | Grant or award · Stock Option (Right to Buy) | +51,000 | 51,000 | ||
| 2026-01-02 | Houghton Adam Chief Business Officer | Grant or award | +25,000 | 25,000 | ||
| 2026-01-02 | Houghton Adam Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2026-01-02 | Sutherland Everett Rand Chief Executive Officer | Grant or award | +75,000 | 75,000 | ||
| 2026-01-02 | Sutherland Everett Rand Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +225,000 | 225,000 | ||
| 2025-06-10 | Ruddy Marcella K. Director | Grant or award · Stock Option (Right to Buy) | +17,096 | 17,096 | ||
| 2025-06-10 | Beckman Daniella Director | Grant or award · Stock Option (Right to Buy) | +17,096 | 17,096 | ||
| 2025-06-10 | Renaud Ronald C JR Director | Grant or award · Stock Option (Right to Buy) | +17,096 | 17,096 | ||
| 2025-06-10 | Fleming Harold Edward Director | Grant or award · Stock Option (Right to Buy) | +17,096 | 17,096 | ||
| 2025-06-10 | Chimovits Erez Director | Grant or award · Stock Option (Right to Buy) | +17,096 | 17,096 | ||
| 2025-06-10 | Ratcliffe Liam Director | Grant or award · Stock Option (Right to Buy) | +17,096 | 17,096 | ||
| 2025-02-06 | Sutherland Everett Rand Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2025-02-06 | GRAY MICHAEL CFO and COO | Grant or award · Stock Option (Right to Buy) | +195,000 | 195,000 | ||
| 2025-02-06 | Houghton Adam Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +140,000 | 140,000 |
Page 2 of 4 · 72 trades